NHS ‘worse than average’ in treating common causes of death
Perfect email campaigns are now easier to launch
Making sure everyone with DMD gets access to treatments and the ‘essential’ interventions that can make life worth living is key.
There are good reasons why patient centricity has become such a well-used term within the pharmaceutical industry. But, says Kantar Health’s Linda VerPlanck, the research approaches underpinning it must be able to deliver transformational insights that can, in turn, improve real-world outcomes.
Humans on a chip
Latest thinking for 21st century drug development